Pregled bibliografske jedinice broj: 68562
Serum Chromogranin A in metastatic prostate cancer patients
Serum Chromogranin A in metastatic prostate cancer patients // Anticancer Research, 16 (1999), 6; 5663-5666 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 68562 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Serum Chromogranin A in metastatic prostate cancer patients
Autori
Tarle, Marko
Izvornik
Anticancer Research (0250-7005) 16
(1999), 6;
5663-5666
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
prostate cancer; metastases; chromogranin A; therapy
Sažetak
We have reported serum chromogranin A and total PSA values in responders and nonresponders to both hormonal therapy and chemohormonal treatment using BPH subjects as controls... Insome nonresponders to Estracyt normal total PSA value together with F/TPSA well bellow 20 indicated contribution of an anaplastic tumor... In accordance with these preliminary data we advocate the CgA serotest assessment in candidates for hormonal therapy as well as during follow-up of pharmacological treatment.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Index Medicus
